A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema

A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema

(1) Background: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is an established treatment for center-involving diabetic macular edema (ci-DME). However, the clinical response is heterogeneous. This study investigated miRNAs as a biomarker to predict treatment response to anti-VEGF...

Full description

Bibliographic Details
Main Authors: Hwei Wuen Chan, Binxia Yang, Wendy Wong, Paul Blakeley, Ivan Seah, Queenie Shu Woon Tan, Haofei Wang, Mayuri Bhargava, Hazel Anne Lin, Charmaine HC Chai, Erlangga Ariadarma Mangunkusumo, Naing Thet, Yew Sen Yuen, Raman Sethi, Si Wang, Walter Hunziker, Gopal Lingam, Xinyi Su
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
anti-vascular endothelial growth factor
aflibercept
bevacizumab
biomarker
diabetic macular edema
microRNA
Online Access:https://www.mdpi.com/2077-0383/9/9/2920

Internet

https://www.mdpi.com/2077-0383/9/9/2920

Similar Items